P

Inventor

CONWAY ANTHONY

US21 patents
⚠️ This page may combine multiple inventors who share the name “CONWAY ANTHONY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SANGAMO THERAPEUTICS INC

12 patents
US10196651B2Feb 5, 2019

Methods and compositions for treatment of a genetic condition

SANGAMO THERAPEUTICS INC16 citations94
US10196652B2Feb 5, 2019

Methods and compositions for treatment of a genetic condition

SANGAMO THERAPEUTICS INC11 citations92
US9833479B2Dec 5, 2017

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

SANGAMO THERAPEUTICS INC5 citations84
US10960085B2Mar 30, 2021

Modulation of liver genes

SANGAMO THERAPEUTICS INC3 citations73
US11690921B2Jul 4, 2023

Delivery of target specific nucleases

SANGAMO THERAPEUTICS INC2 citations68
US12043650B2Jul 23, 2024

Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

SANGAMO THERAPEUTICS INC0 citations62
US11655275B2May 23, 2023

Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

SANGAMO THERAPEUTICS INC0 citations62
US12516098B2Jan 6, 2026

Chimeric antigen receptor mediated cell targeting

SANGAMO THERAPEUTICS INC0 citations55
US12509703B2Dec 30, 2025

Controlled transgene expression in regulatory t cells

SANGAMO THERAPEUTICS INC0 citations51
US11661611B2May 30, 2023

Genetic modification of cytokine inducible SH2-containing protein (CISH) gene

SANGAMO THERAPEUTICS INC0 citations51
US11020492B2Jun 1, 2021

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

SANGAMO THERAPEUTICS INC0 citations51
US11512287B2Nov 29, 2022

Targeted disruption of T cell and/or HLA receptors

SANGAMO THERAPEUTICS INC0 citations49

BRITISH TELECOMM

5 patents

SANGAMO BIOSCIENCES INC

4 patents